In 2005 it became part of the Genextra Group, a holding active in the biotech and drug discovery field, and extended its research activities in biotechnology area, aiming to identify applications of its own coating technology.
At present, Tethis’ main activities are:
Manufacture and sale
of lab equipments for the production of nanopowders and nanoparticle coating based on a flame-synthesis process.
High quality R&D
for the integration of functional material into innovative devices. Tethis’ joint efforts focus on the realization of proof-of-concept devices based on the synergetic contribution of nano-, bio-, and microfabrication technologies.